PAYX
48
-6
RL
69
-4
WM
74
-5
LB
30
4
RIG
43
-7
APH
65
-3
BEN
50
9
SHW
62
-6
AMAT
33
-13
ISRG
71
-5
BXP
49
-3
TDC
67
-4
SJM
9
-5
BA
47
2
GS
72
4
ACN
47
-5
KO
38
-3
AN
50
-5
FTI
71
-7
PCAR
56
-5
PAYX
48
-6
RL
69
-4
WM
74
-5
LB
30
4
RIG
43
-7
APH
65
-3
BEN
50
9
SHW
62
-6
AMAT
33
-13
ISRG
71
-5
BXP
49
-3
TDC
67
-4
SJM
9
-5
BA
47
2
GS
72
4
ACN
47
-5
KO
38
-3
AN
50
-5
FTI
71
-7
PCAR
56
-5
Financhill
Back

USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
47

SDCI
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF

Last Price:
19.70
Seasonality Move:
-2.41%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
47
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF (SDCI) is a Sell

Is USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF a Buy, Sell or Hold?

  • The current USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF [SDCI] share price is $19.70. The Score for SDCI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • SDCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SDCI Stock Price Chart

What is USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF's stock price today?

  • The USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF share price today is $19.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SDCI is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SDCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 52.71 Buy
Chaikin Money Flow: -8351 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.44 - 19.76) Buy
Bollinger Bands (100): (18.78 - 19.68) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SDCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.69 Buy
20-day SMA: 19.62 Buy
50-day SMA: 19.44 Buy
200-day SMA: 19.05 Buy
8-day EMA: 19.68 Buy
20-day EMA: 19.64 Buy
50-day EMA: 19.48 Buy
200-day EMA: 19.07 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF Earnings Growth & SDCI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):